Nicolas Verheyen, Res Prof, MD PhD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Wild type ATTR amyloidosis→

Clinical trials (1)

• NCT06261216

Verify independently

• ClinicalTrials.gov PI search for Nicolas Verheyen, Res Prof, MD PhD

Other specialists for Wild type ATTR amyloidosis

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Mazen Hanna, MD, M.D
  The Cleveland Clinic
  OH
• Adalgisa Condoluci, MD
  Oncology Institute of Southern Switzerland
• Mathew S Maurer, MD
  Columbia University
• John L Berk, M.D., D.D.S
  Boston University
  CA
• Torstein Hole, MD, PhD
  Helse Møre og Romsdal HF and NTNU
• Jeff Packman, MBA
  FoldRx Pharmaceuticals, Inc
• MARK MCGOVERN, RN
  Eidos Therapeutics, a BridgeBio company
• Thibaud DAMY, MD PhD
  CHU Henri Mondor, Paris

See all specialists for Wild type ATTR amyloidosis →